Literature DB >> 1520290

A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts.

R Thweatt1, C K Lumpkin, S Goldstein.   

Abstract

In order to identify genes that may be causally involved in replicative senescence, we have isolated several gene sequences that are overexpressed in senescent human fibroblasts by differential screening of a cDNA library derived from mRNA of a subject with Werner syndrome of premature aging (Murano, S., et al., Molec. Cell. Biol., 3905-3914, 1991). Herein, we describe the sequence and expression of one of these genes, WS3-10, which encodes a novel human cytoplasmic protein of 22.5 kilodaltons. The steady-state mRNA levels of WS3-10 mRNA were higher in WS and late-passage normal cells compared to early-passage normal cells following serum depletion and subsequent repletion. Computer analysis showed similarities between WS3-10 and certain proteins in other species, indicating that WS3-10 represents the human homolog of a smooth muscle protein involved in calcium interactions that may contribute to replicative senescence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520290     DOI: 10.1016/s0006-291x(05)81449-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Role of smooth muscle protein SM22α in glomerular epithelial cell injury.

Authors:  Caroline B Marshall; Ron D Krofft; Mary J Blonski; Jolanta Kowalewska; Christine M Logar; Jeffrey W Pippin; Francis Kim; Robert Feil; Charles E Alpers; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

2.  Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function.

Authors:  J C Zhang; S Kim; B P Helmke; W W Yu; K L Du; M M Lu; M Strobeck; Q Yu; M S Parmacek
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.

Authors:  Y E Chang; L A Laimins
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Role of SM22 in the differential regulation of phasic vs. tonic smooth muscle.

Authors:  Satish Rattan; Mehboob Ali
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-23       Impact factor: 4.052

5.  The Saccharomyces cerevisiae calponin/transgelin homolog Scp1 functions with fimbrin to regulate stability and organization of the actin cytoskeleton.

Authors:  Anya Goodman; Bruce L Goode; Paul Matsudaira; Gerald R Fink
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

6.  Cloning and analysis of the promoter region of the rat SM22 alpha gene.

Authors:  P R Kemp; J K Osbourn; D J Grainger; J C Metcalfe
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

7.  Suppression of calcium-dependent membrane currents in human fibroblasts by replicative senescence and forced expression of a gene sequence encoding a putative calcium-binding protein.

Authors:  S Liu; R Thweatt; C K Lumpkin; S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells.

Authors:  Oliver Thompson; Jeelan S Moghraby; Kathryn R Ayscough; Steve J Winder
Journal:  BMC Cell Biol       Date:  2012-01-18       Impact factor: 4.241

9.  Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein.

Authors:  C Shapland; J J Hsuan; N F Totty; D Lawson
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

10.  Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer.

Authors:  Nilufer Sayar; Gurbet Karahan; Ozlen Konu; Betul Bozkurt; Onder Bozdogan; Isik G Yulug
Journal:  Clin Epigenetics       Date:  2015-09-28       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.